Showing 20 of 45 recruiting trials for “Meningioma”
RecruitingNCT06466720 ↗
Measuring and Mapping Cognitive Decline After Brain Radiosurgery
👨⚕️ Paul S Morgan, Professor of Medical Physics, University of Nottingham📍 1 site📅 Started Jun 2024View details ↗
FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery
👨⚕️ Jane Skjøth-Rasmussen, MD, PhD, Department of neurosurgery, Rigshospitalet📍 1 site📅 Started May 2024View details ↗
Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III Study
Plasma Extracellular Vesicles in Meningioma Patients
Cryoablation of Brain Neoplasm
Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
👨⚕️ Javier Villanueva-Meyer, MD, University of California, San Francisco📍 1 site📅 Started Sep 2023View details ↗
Neurocognition After Radiotherapy in CNS- and Skull-base Tumors
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
Embolization for Meningioma
👨⚕️ Ole Solheim, PhD, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway📍 1 site📅 Started Oct 2022View details ↗
NEO100 and High-Grade Meningioma
Cabozantinib for Patients With Recurrent or Progressive Meningioma
👨⚕️ Rupesh Kotecha, M.D., Miami Cancer Institute at Baptist Health, Inc.📍 3 sites📅 Started Jun 2022View details ↗
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide
👨⚕️ Dominik Cordier, PD Dr. med., University Hospital, Basel, Switzerland📍 1 site📅 Started Apr 2021View details ↗
RecruitingNCT04638478 ↗
PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
👨⚕️ Nancy Oberheim Bush, MD, PhD, University of California, San Francisco📍 1 site📅 Started Mar 2021View details ↗
Predictive Factors for Survival in Aggressive Meningiomas
🏥 Fondazione Policlinico Universitario Agostino Gemelli IRCCS📍 1 site📅 Started Jan 2021View details ↗
RecruitingNCT04427384 ↗
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
👨⚕️ Bree R Eaton, Emory University Hospital/Winship Cancer Institute📍 1 site📅 Started Feb 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →